Mark Gorelik1, Satya D Narisety2, Anthony L Guerrerio3, Kristin L Chichester1, Corinne A Keet1, Anja P Bieneman4, Robert G Hamilton4, Robert A Wood1, John T Schroeder4, Pamela A Frischmeyer-Guerrerio5. 1. Department of Pediatrics, Division of Allergy and Immunology, Johns Hopkins University School of Medicine, Baltimore, Md. 2. Department of Pediatrics, Division of Allergy, Immunology and Infectious Diseases, University of Medicine and Dentistry of New Jersey, Newark, NJ. 3. Department of Pediatrics, Division of Gastroenterology and Nutrition, Johns Hopkins University School of Medicine, Baltimore, Md. 4. Department of Medicine, Division of Allergy and Immunology, Johns Hopkins University School of Medicine, Baltimore, Md. 5. Department of Pediatrics, Division of Allergy and Immunology, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: pamela.guerrerio@nih.gov.
Abstract
BACKGROUND: Studies suggest that oral immunotherapy (OIT) and sublingual immunotherapy (SLIT) for food allergy hold promise; however, the immunologic mechanisms underlying these therapies are not well understood. OBJECTIVE: We sought to generate insights into the mechanisms and duration of suppression of immune responses to peanut during immunotherapy. METHODS: Blood was obtained from subjects at baseline and at multiple time points during a placebo-controlled trial of peanut OIT and SLIT. Immunologic outcomes included measurement of spontaneous and stimulated basophil activity by using automated fluorometry (histamine) and flow cytometry (activation markers and IL-4), measurement of allergen-induced cytokine expression in dendritic cell (DC)-T-cell cocultures by using multiplexing technology, and measurement of MHC II and costimulatory molecule expression on DCs by using flow cytometry. RESULTS: Spontaneous and allergen-induced basophil reactivity (histamine release, CD63 expression, and IL-4 production) were suppressed during dose escalation and after 6 months of maintenance dosing. Peanut- and dust mite-induced expression of TH2 cytokines was reduced in DC-T-cell cocultures during immunotherapy. This was associated with decreased levels of CD40, HLA-DR, and CD86 expression on DCs and increased expression of CD80. These effects were most striking in myeloid DC-T-cell cocultures from subjects receiving OIT. Many markers of immunologic suppression reversed after withdrawal from immunotherapy and in some cases during ongoing maintenance therapy. CONCLUSION: OIT and SLIT for peanut allergy induce rapid suppression of basophil effector functions, DC activation, and TH2 cytokine responses during the initial phases of immunotherapy in an antigen-nonspecific manner. Although there was some interindividual variation, in many patients suppression appeared to be temporary. Published by Elsevier Inc.
BACKGROUND: Studies suggest that oral immunotherapy (OIT) and sublingual immunotherapy (SLIT) for food allergy hold promise; however, the immunologic mechanisms underlying these therapies are not well understood. OBJECTIVE: We sought to generate insights into the mechanisms and duration of suppression of immune responses to peanut during immunotherapy. METHODS: Blood was obtained from subjects at baseline and at multiple time points during a placebo-controlled trial of peanut OIT and SLIT. Immunologic outcomes included measurement of spontaneous and stimulated basophil activity by using automated fluorometry (histamine) and flow cytometry (activation markers and IL-4), measurement of allergen-induced cytokine expression in dendritic cell (DC)-T-cell cocultures by using multiplexing technology, and measurement of MHC II and costimulatory molecule expression on DCs by using flow cytometry. RESULTS: Spontaneous and allergen-induced basophil reactivity (histamine release, CD63 expression, and IL-4 production) were suppressed during dose escalation and after 6 months of maintenance dosing. Peanut- and dust mite-induced expression of TH2 cytokines was reduced in DC-T-cell cocultures during immunotherapy. This was associated with decreased levels of CD40, HLA-DR, and CD86 expression on DCs and increased expression of CD80. These effects were most striking in myeloid DC-T-cell cocultures from subjects receiving OIT. Many markers of immunologic suppression reversed after withdrawal from immunotherapy and in some cases during ongoing maintenance therapy. CONCLUSION: OIT and SLIT for peanutallergy induce rapid suppression of basophil effector functions, DC activation, and TH2 cytokine responses during the initial phases of immunotherapy in an antigen-nonspecific manner. Although there was some interindividual variation, in many patients suppression appeared to be temporary. Published by Elsevier Inc.
Authors: Yong Zheng; Claire N Manzotti; Michael Liu; Fiona Burke; Karen I Mead; David M Sansom Journal: J Immunol Date: 2004-03-01 Impact factor: 5.422
Authors: Andrea Denzel; Ulrich A Maus; Manuel Rodriguez Gomez; Cordula Moll; Marianne Niedermeier; Christine Winter; Regina Maus; Susan Hollingshead; David E Briles; Leoni A Kunz-Schughart; Yvonne Talke; Matthias Mack Journal: Nat Immunol Date: 2008-05-30 Impact factor: 25.606
Authors: Satya D Narisety; Pamela A Frischmeyer-Guerrerio; Corinne A Keet; Mark Gorelik; John Schroeder; Robert G Hamilton; Robert A Wood Journal: J Allergy Clin Immunol Date: 2014-12-18 Impact factor: 10.793
Authors: Wayne G Shreffler; Russell R Castro; Z Yesim Kucuk; Zachary Charlop-Powers; Galina Grishina; Steven Yoo; A Wesley Burks; Hugh A Sampson Journal: J Immunol Date: 2006-09-15 Impact factor: 5.422
Authors: Stacie M Jones; Laurent Pons; Joseph L Roberts; Amy M Scurlock; Tamara T Perry; Mike Kulis; Wayne G Shreffler; Pamela Steele; Karen A Henry; Margaret Adair; James M Francis; Stephen Durham; Brian P Vickery; Xiaoping Zhong; A Wesley Burks Journal: J Allergy Clin Immunol Date: 2009-07-03 Impact factor: 10.793
Authors: Stacie M Jones; A Wesley Burks; Corinne Keet; Brian P Vickery; Amy M Scurlock; Robert A Wood; Andrew H Liu; Scott H Sicherer; Alice K Henning; Robert W Lindblad; Peter Dawson; Cecilia Berin; David M Fleischer; Donald Y M Leung; Marshall Plaut; Hugh A Sampson Journal: J Allergy Clin Immunol Date: 2016-03-09 Impact factor: 10.793
Authors: B L Wright; M Kulis; K A Orgel; A W Burks; P Dawson; A K Henning; S M Jones; R A Wood; S H Sicherer; R W Lindblad; D Stablein; D Y M Leung; B P Vickery; H A Sampson Journal: Allergy Date: 2016-06-13 Impact factor: 13.146
Authors: Brian P Vickery; Jelena P Berglund; Caitlin M Burk; Jason P Fine; Edwin H Kim; Jung In Kim; Corinne A Keet; Michael Kulis; Kelly G Orgel; Rishu Guo; Pamela H Steele; Yamini V Virkud; Ping Ye; Benjamin L Wright; Robert A Wood; A Wesley Burks Journal: J Allergy Clin Immunol Date: 2016-08-10 Impact factor: 10.793